Kim Kardashian, one of the most recognizable figures in entertainment and fashion, has once again drawn global attention—not for a red carpet appearance or a business venture, but for a medical journey that took her beyond U.S. borders. At 44, the reality star and entrepreneur revealed that she traveled to Mexico with her sister Khloé Kardashian to undergo Muse stem cell therapy, a regenerative medical procedure not approved for general use in the United States.
The treatment was administered at Eterna Health, a regenerative medicine clinic in Mexico, under the supervision of Dr. Adeel Khan, a physician known internationally for his work with advanced cell-based therapies. On Instagram, Kardashian shared a series of images documenting her experience inside the facility. The photos showed her dressed in black pajamas with protective dark goggles, posing alongside Dr. Khan, and even lying face-down mid-procedure, with visible traces of what appeared to be blood on her back.
Understanding Muse Stem Cell Therapy
Muse cells—short for Multilineage Differentiating Stress-Enduring cells—are a unique type of naturally occurring stem cell found in adult connective tissue, including bone marrow, peripheral blood, and umbilical cord. Unlike many other pluripotent stem cells, Muse cells do not typically form tumors and have a lower risk of immune rejection when transplanted, making them an attractive focus of research in regenerative medicine.
In laboratory and early clinical studies, Muse cells have been shown to home directly to sites of injury, differentiate into the needed tissue types, and integrate into existing structures, contributing to repair in muscles, joints, and even certain organs. Scientists believe that these properties could make them valuable for treating a wide range of conditions—from orthopedic injuries to neurological damage—although most potential uses are still in the experimental stage.
At Eterna Health, the clinic claims that Muse stem cell therapy can promote “complete cellular renewal” by replacing damaged or compromised cells with fully functional ones, particularly in targeted areas such as joints, spinal tissues, and muscles. The procedure involves extracting and preparing the cells, then administering them to the site of injury or pain.
How Kardashian’s Interest Began
Kardashian first turned to Muse stem cell therapy two years ago after sustaining a significant shoulder injury while weight training. The injury caused severe and persistent pain, making certain movements difficult and limiting her ability to exercise. According to her account, she pursued various traditional and alternative treatments in the United States but did not find lasting relief.
Upon learning about Dr. Khan’s work in Mexico, she decided to try Muse therapy. After undergoing the treatment, she reported that her shoulder’s range of motion returned, and the chronic pain that had been impacting her daily life resolved completely.
Encouraged by these results, Kardashian returned to Eterna Health to address another long-term issue: chronic back pain. She described this pain as something she had endured for years, affecting her comfort and mobility. Following the procedure in Mexico, she reported that the pain subsided almost immediately, allowing her to move more freely and perform daily activities without discomfort.
Why She Went Abroad for Treatment
Muse stem cell therapy is not banned in the United States, but it is not FDA-approved for general clinical use. The U.S. Food and Drug Administration only authorizes specific stem cell therapies—such as umbilical cord blood stem cells for treating certain blood disorders—while other regenerative applications remain under investigation in clinical trials. Because Muse therapy falls into the category of experimental treatments, it cannot be offered as a standard medical service in the U.S.
This regulatory limitation has led many patients seeking advanced regenerative treatments to travel abroad. Countries like Mexico, Panama, and the Cayman Islands have more flexible frameworks for approving and administering stem cell-based procedures, allowing private clinics to offer therapies still in the research phase in the U.S.
Public Reaction: Praise, Skepticism, and Concerns
Kardashian’s decision to publicly share her experience drew a mixed response. Many followers expressed appreciation for her openness about a treatment that is not widely known, seeing her story as a window into the possibilities of regenerative medicine. Some with similar injuries or chronic pain were intrigued by the potential of Muse therapy and expressed interest in learning more.
However, others were critical—pointing out that the therapy’s cost, estimated between $4,000 and $15,000 per session (excluding international travel, accommodations, and recovery expenses), makes it accessible only to those with significant financial resources. Critics argued that her ability to access and promote such procedures highlights the gap between medical innovation and public accessibility.
Medical experts also weighed in, noting that while Muse cells have shown promise in early studies, more large-scale clinical trials are needed to fully understand their effectiveness and long-term safety. They cautioned that individual success stories, while encouraging, should not be interpreted as guaranteed outcomes for all patients.
The Bigger Picture: Innovation vs. Accessibility
Kardashian’s stem cell journey underscores a larger debate within modern healthcare: how to balance the rapid pace of medical innovation with the need for thorough scientific validation and equitable access. Regenerative medicine—particularly cell-based therapies—is advancing faster than regulatory frameworks can adapt. As a result, patients with the means to travel internationally may gain early access to groundbreaking treatments, while others must wait years for formal approvals in their home countries.
For now, Kardashian’s experience serves as both an example of the potential benefits of cutting-edge science and a reminder that these benefits remain out of reach for many. Her high-profile platform ensures the therapy will attract more public attention, which could in turn increase demand, fuel more research, and possibly accelerate the path toward broader approval.
